Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

ndtv.com - Sensex Rises Over 250 Points, Nifty Above 16,300; IT, Pharma Stocks Surge
Sensex Rises Over 250 Points, Nifty Above 16,300; IT, Pharma Stocks Surge
NDTV

Sensex and Nifty started on a higher note today. New Delhi: Indian equity benchmarks on Wednesday rose in opening deals led by gains in information technology and pharma stocks. Asian shares struggled to carry recent gains into a fourth straight…

zawya.com - Cleofe Maceda - Abu Dhabi-listed pharma Julphar more than doubles sales after turnaround plan
Abu Dhabi-listed pharma Julphar more than doubles sales after turnaround plan
ZAWYA

Gulf Pharmaceutical Industries (Julphar), one of the region's biggest drug manufacturers, swung to a net profit in the first quarter of 2022 as sales more than doubled following a “strategic turnaround plan”. Net profit for the…

globenewswire.com - Zealand Pharma - Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go Insulin Delivery Device
Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go Insulin Delivery Device
GlobeNewswire

Company announcement – No. 21 / 202 2 Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-G o Insulin Delivery Device Deal includes $10 million USD upfront payment to Zealand and sales-based milestones Certain…

mmm-online.com - Five things for pharma marketers to know: Tuesday, May 17, 2022
Five things for pharma marketers to know: Tuesday, May 17, 2022
Medical Marketing & Media

Bristol Myers Squibb announced its Opdivo/Yervoy combo therapy for bladder cancer failed in a Phase III study. “Despite some progress in recent years, metastatic urothelial carcinoma remains a difficult disease to address, with a limited…

vccircle.com - Multiples PE-led consortium acquires 9.3% stake in BDR Pharma
Multiples PE-led consortium acquires 9.3% stake in BDR Pharma
VCCircle

A consortium led by private equity firm Multiples Alternate Asset Management Pvt. Ltd has bought 9.3% stake in Mumbai-based BDR Pharmaceuticals International for Rs 685 crore (around $88 million). BDR Pharmaceuticals will use the capital to boost…

globenewswire.com - Emergex Vaccines Holding Ltd - Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma's Micro-Needle Patch
Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma's Micro-Needle Patch
GlobeNewswire

Em erge x Vaccines Announce s t he Successful Coating o f i ts Novel CD8 + T cell Adaptive COVID -19 V accine o nto Zosano Pharma's Micro- Needle Patch Emergex 's COVID-19 and Dengue CD8 + T cell Adaptive v accines are already in clinical trials…

theverge.com - Jordyn Haime - How fears of electromagnetic radiation spawned a snake-oil industry
How fears of electromagnetic radiation spawned a snake-oil industry
The Verge

The pager-sized stainless steel Springlife polarizer looks like not much more than a small metal box. The “sound healing energy” website that sells it claims that it's made up of “special minerals and Earth substances”…

business-standard.com - SI Reporter - MARKET LIVE: Sensex rises 400 points, Nifty nears 16,400; IT, pharma lead
MARKET LIVE: Sensex rises 400 points, Nifty nears 16,400; IT, pharma lead
Business Standard

Last Updated at May 18, 2022 09:58 IST Stock market live updates: The key benchmark indices held firm gains in early deals on Wednesday. The BSE Sensex rose 400 points to 54,740, and the NSE Nifty50 rose 130 points to 16,400. Bharti Airtel…

economist.com - Commercialising Quantum | May 17th - 19th 2022
Commercialising Quantum | May 17th - 19th 2022
The Economist

Minister for science, research and innovation, department for business, energy & industrial strategy, UK Government X Minister for science, research and innovation, department for business, energy & industrial strategy, UK Government May 17th 2022…

medicaldialogues.in - MD Bureau - Takeda Pharma unveils haemophilia drug Adynovate in India
Takeda Pharma unveils haemophilia drug Adynovate in India
Medical Dialogues

New Delhi: A USFDA-approved treatment that may prevent haemophilia, a rare bleeding disorder, has been launched in India for the first time, global biopharmaceutical company Takeda Pharmaceutical said on Monday. A genetic condition that prevents…

ft.com - Anjana Ahuja - Digital enchantment holds too much sway over big tech regulation
Digital enchantment holds too much sway over big tech regulation
Financial Times

There is a critical balance to be struck between pushing boundaries while grasping that those limits exist for a reason Receive free Technology sector updates We'll send you a myFT Daily Digest email rounding up the latest Technology sector news…

nature.com - Artificial intelligence makes a splash in small-molecule drug discovery
Artificial intelligence makes a splash in small-molecule drug discovery
Nature

In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights…

medicaldialogues.in - ruchika - GlaxoSmithKline Pharma posts net loss at Rs 55 crore in Q4
GlaxoSmithKline Pharma posts net loss at Rs 55 crore in Q4
Medical Dialogues

Published On 2022-05-17 10:37 GMT | Update On 2022-05-17 10:37 GMT New Delhi: GlaxoSmithKline Pharmaceuticals on Monday reported a Rs 55 crore consolidated net loss from continuing operations for the fourth quarter. The drug firm had reported a net…

livemint.com - Joseph Rai - Multiples PE-led consortium invests $88 mn in BDR Pharma
Multiples PE-led consortium invests $88 mn in BDR Pharma
mint

NEW DELHI: Private equity firm Multiples Alternate Asset Management Pvt. Ltd-led consortium has invested ₹685 crore, or around $88 million, in drugmaker BDR Pharmaceuticals International for a 9.3% stake. NEW DELHI: Private equity firm…

syracuse.com - Rick Moriarty | rmoriarty@syracuse.com - How sale of Bristol's East Syracuse pharma plant to Lotte could be a boon to Central NY
How sale of Bristol's East Syracuse pharma plant to Lotte could be a boon to Central NY
syracuse

Syracuse, N.Y. -- The $160 million sale of Bristol Myers Squibb's pharmaceutical plant in East Syracuse could expand business here in a big way as South Korea's fifth-largest company takes it first steps toward a new venture: making medicines.

Receive a Daily briefing on Pharma Industry News

Get Started